After 11 days of tumor engraftment, mice were injected with PBS (n = 3) or 6 × 106 CD8 T-cells transduced with the HLA-A11-restricted dNPM1 TCR (n = 8), the HLA-A11-restriced EBV TCR as negative control (n = 7) or the HLA-A2-restricted dNPM1 TCR as positive control (n = 5). Here, CD8A is linked to neoplasm.